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Gregory L. Moneta, MD, Section EditorAngioplasty and Stent Placement in Symptomatic Internal Carotid
Occlusion
Puech-Leão P, Bregalda Neves CR, Simão da Silva E, et al. J Vasc Intervent
Rad 2010;21:465-9.
Conclusion: Carotid artery angioplasty and stenting can be success-
fully performed in patients with internal carotid artery pseudo-occlusion or
string sign.
Summary: This report focuses on carotid angioplasty and stenting in a
series of patients in whom the internal carotid artery (ICA) was thought
occluded by conventional ultrasound but who actually had string signs. The
authors treated 16 patients. Contrast computed tomography (CT) showed a
patent distal ICA in 14 of the 16 patients treated. Contrast-enhanced
ultrasound imaging also showed patent distal ICAs in 13 cases.
This is actually a series of very high-grade ICA stenosis and/or string
signs treated with angioplasty and stenting. The authors performed the
angioplasty and stent placement under cerebral protection. Duplex imaging
was performed at 14 days, 3 months, and every 6 months thereafter. CT
scans were obtained at 2 to 9 months, and the mean follow-up period was
9.9 months. Most patients had nonhemispheric symptoms as the indication
for treatment. Patients were treated with clopidogrel and aspirin before the
procedure and were maintained on clopidogrel 90 days after treatment and
on aspirin indefinitely. A 6F sheath was placed in the common carotid artery
and the ICA accessed with a 5F diagnostic vertebral catheter. A 0.035-inch
hydrophilic guide wire was then passed into the ICA, followed by the
catheter. An interceptor filter (Medtronic, Minneapolis, MN) was passed
through the catheter and opened in the lumen, and then the catheter was
withdrawn. Predilation was performed with a 3-mm balloon through the
filter wire, and then a self-expanding stent was placed in the proximal ICA and
dilated with a 5-mm balloon. If necessary, a second distal stent was placed.
Stent placement was successful in 13 of 16 patients. There were no
deaths, conversions, or cardiac complications. One patient had paresis in the
upper limb with recovery in 3 months. At follow-up, all 13 patients remained
with patent arterial lumens and were symptom free. After 2 to 9 months,
so-called string signs had calibers close or equal to those of normal arteries.
Comment: The title of this article is misleading. Although conven-
tional duplex ultrasound imaging showed the patients had occluded ICAs,
all in fact had patent distal ICAs either by contrast-enhanced ultrasound or
contrast CT scanning. The authors of the article, the Journal of Vascular and
Interventional Radiology reviewers, and the editors should be ashamed for
permitting such a misleading title. What the authors have shown us is that in
their institution, conventional duplex ultrasound imaging is likely below
standard in distinguishing high-grade carotid stenosis from occlusion. They
have shown us that CT angiography and contrast-enhanced ultrasound
imaging can detect carotid string signs, something we already knew. They
have also shown us that if you can get a wire across a high-grade stenosis,
then you can perform angioplasty and stenting, again something we already
knew. They have demonstrated that such procedures can be performed, but
whether they should be performed is an entirely different question.
A Large-Scale Study of the Upper Arm Basilic Transposition for
Hemodialysis
Glass C, Porter J, Singh M, et al. Ann Vasc Surg 2010;24:85-91.
Conclusion: Basilic vein transposition fistulas have excellent matura-
tion rates and good functional patency at 1 year. Major limitations to
long-term durability are the need for frequent revisions and central venous
stenosis.
Summary: The fistula-first initiative set a goal of 65% prevalence of
autogenous fistulas for hemodialysis access to be achieved in the United
States by 2009. Multiple studies in the recent past (10 during 2007-2009
alone) have examined maturation and patency rates of basilic vein transpo-
sition. The authors used basilic vein transposition as their third choice in the
construction of dialysis access, with radiocephalic the first choice and bra-
chiocephalic fistula the second choice. In this article they reviewed the results
of basilic vein transposition from April 2001 to June 2008. This retrospec-
tive study included information on demographics, volume flow creation,
maturation and patency rates, postoperative complications, and the need for
secondary interventions as well as overall mortality.
There were 217 upper arm basilic vein transposition fistulas in the
study. Fifty-three percent of the patients were men and there were 215
patients with a mean of 2.9 previous surgical access attempts before basilic
vein transposition. Only 14% of the time was basilic vein transposition the
initial fistula. Mean flow at time of fistula creation was 347 mL/min (range,
10-880 mL/min). The maturation rate was 87%. Mortality related to theprocedure was 0.5%. At 6, 12, and 24 months, primary patency rates were
63%, 40%, and 26%, and primary assisted patency rates were 74%, 56%, and
38%, respectively. Secondary patency rates at 6, 12, and 24 months were
85%, 72%, and 65%, respectively. The most common complication before
maturation was fistula thrombosis (16%), and the most frequent cause of
fistula failure was central venous stenosis (22%).
Comment: What makes this article stand out among the numerous
reports on basilic vein transposition have been published in the recent past is the
very high initial maturation rate. The authors attribute this to a technical
modification of the procedure. They noted previously that an area of the vein in
the upper part of the wound as it passes centrally was a frequent site of intimal
hyperplasia. They hypothesize this was caused by tethering of the vein by a large
profunda branch in the upper arm. The authors now routinely divide this branch
and all entering veins as high as they can reach in the axilla and postulate that the
smoother course of the transposition that this allows results in improved
maturation. The division of the profunda vein appears to cause no significant
complications, and therefore, it seems reasonable to incorporate this technical
modification of basilic vein transposition into the operation.
A Comparison of Clopidogrel Responsiveness in Patients With versus
Without Chronic Renal Failure
Park SH, Kim W, Park CS, et al. Am J Cardiol 2009;104:1292-5.
Conclusion: Patients with chronic renal failure have decreased respon-
siveness to clopidogrel compared with patients without chronic renal failure.
This decreased responsiveness is not corrected by an increase in the clopi-
dogrel dosage.
Summary: No antiplatelet effects are detectable in up to 30% of
patients receiving clopidogrel. It has been shown that chronic renal failure
(CRF) is a risk factor for stent thrombosis (J Am Coll Card 2007;50:501-8).
The present study was therefore performed to assess platelet responsiveness
to clopidogrel in patients with CRF. CRF was designated as a serum
creatinine3 mg/dL, and platelet responsiveness was expressed in terms of
P2Y12 reaction units (PRUs) and baseline PRUs in percentage of inhibition.
The effects of drugs that selectively act on the P2Y12 receptor can be
evaluated when adenosine diphosphate, a platelet receptor stimulator, is
mixed with prostaglandin E1. In these cases, the P2Y12 receptors activated
by adenosine diphosphate are inhibited by prostaglandin E1. Baseline PRU
values are measured using thrombin receptor-activating peptide. The per-
centage of platelet inhibition by clopidogrel is calculated by using the
baseline PRU value and the PRU value obtained after administration of
clopidogrel.
The study was performed in Korea and 94.4% of participants were men.
Patients with CRF for 6 months were randomized assigned to receive 75
mg of clopidogrel daily (group II, n  18) or 150 mg of clopidogrel daily
(group III, n 18). Group I was a control group with normal renal function
(n 23). Groups I and II received a once-daily dose of 75 mg of clopidogrel
for 4 weeks, and group III received a once-daily dose of 150 mg of
clopidogrel for 4 weeks. Primary efficacy variables among the groups were
the PRU value and the percentage of inhibition. There was a significant
difference in the PRU values among the three groups (232 86 in group I,
308  70 in group II, 302  81 in group III; P  .013) and in the
percentage of inhibition (35 20 in group I, 21 16 in group II, 23 14
in group III; P  .026). There were no significant differences in PRUs or
percent inhibition between groups II and III.
Comment: The study has several limitations that preclude its applica-
tion to all populations. Most specifically, almost all participants were men
and it was conducted in an exclusively Korean population. Nevertheless, it
highlights the potential adverse effect of renal failure on clopidogrel effec-
tiveness. Clinicians are left in a bit of a difficult situation in that it appears
renal failure makes clopidogrel less effective. In addition, this lack of effec-
tiveness cannot be overcome by doubling the dose. However, this study used
only one measure of platelet inhibition by clopidogrel. The drug may have
other effects that are beneficial in patients with renal failure that are not
measured by the methodology that was used.
Infectious Burden and Carotid Plaque Thickness: The Northern Man-
hattan Study
Elkind MSV, Luna JM, Moon YP, et al. Stroke 2010;41:e117-22.
Conclusion: Carotid plaque thickness in a multiethnic cohort is asso-
ciated with a quantitative weighted index of infectious burden derived from
the magnitude of association of individual infections with stroke.
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infectious agents such as Helicobacter pylori, Chlamydia pneumoniae, and
herpes viruses to coronary artery disease and stroke (Wimmer MLJ, et al
[Stroke 1996;27:2207-10] and Ridker PM et al [Circulation 1998;98:
2796-2799]) with atherosclerosis. It has been thought that chronic infec-
tions may lead to an inflammatory process through remote signaling of
inflammatory mediators that ultimately begin the process of atherosclerosis.
The authors postulate that it is more likely that an aggregate of infectious
burden, rather than a single infection, would lead to such a proinflammatory
state.
This study measured antibody titers to common infectious microor-
ganisms (Chlamydia pneumoniae, Helicobacter pylori, cytomegalovirus, and
herpes viruses 1 and 2) in community participants who were stroke free. A
weighted index of infectious burden was then calculated based on Cox
models derived from the association of each infection with stroke risk.
Maximum carotid plaque thickness was then determined with high-
resolution carotid artery duplex scanning. The association between in-
fectious burden and maximum carotid plaque thickening after adjust-
ment for other risk factors was determined using weighted least squares
regression.
Serologic results for all five infectious organisms were available for 861
participants (mean age, 67.2 9.6 years) in whom maximum carotid plaque
thickness measurements were also available. The infectious burden index was
a mean of 1.0  0.35 (median, 1.08), and 52% of the participants had
detectible plaque (mean, 0.90  1.04 mm). Infectious burden was associ-
ated with maximum carotid plaque thickness (adjusted increase in maximum
carotid plaque thickness 0.09 mm; 95% confidence interval, 0.03-0.15 mm
per standard deviation increase of infectious burden).
Comment: An implication of the study is that infectious burden may
be a modifiable risk of atherosclerosis and that measurement of carotid
plaque thickness may provide a way to assess the effects of an anti-infective
strategy. A weakness of the study is that serologic measurements of infection
and carotid plaque thickness were determined at only a single time. Tempo-
ral relationships between carotid plaque thickness and infectious burden
cannot be determined from these data. Another problem with the infectious
etiology of atherosclerosis theory is that clinical trials of antibiotic therapy for
infectious agents thought to be associated with atherosclerosis have not been
shown to reduce vascular risk (O’Connor CM, et al [JAMA 2003;2901:
1459-66] and Cameron CP, et al [N Engl J Med 2005;352:1646-54]).
Limb-Shaking Transient Ischaemic Attacks in Patients With Internal
Carotid Artery Occlusion: A Case-Control Study
Persoon S, Kappelle LJ, Klijn CJM. Brain 2010;133:915-22.
Conclusion: Transient ischemic attacks (TIAs) marked by limb-
shaking are associated with high-grade carotid stenosis or internal carotid
artery occlusion and can be recognized by short duration and precipitation
by rising or exercise. They are also accompanied frequently by paresis and
indicate an impaired hemodynamic state of the brain.
Summary: Case-reports have described limb-shaking as an unusual
clinical feature of TIAs (Klijn CJ, et al [Neurology 2000; 55: 1806-12] and
Firlik AD, et al [Neurosurgery 1996;39:607-11]). The limb-shaking char-
acterizing these TIAs consists of brief, jerky, and coarse involuntary move-
ments involving an arm or a leg and has been associated with high-grade
stenosis or occlusion of the internal carotid artery (ICA). An unanswered
question is whether patients with high-grade ICA stenosis or occlusion who
have limb-shaking TIAs have a worse hemodynamic flow state than patients
with ICA stenosis or occlusion who do not have limb-shaking TIAs. In this
study the authors sought to describe clinical characteristics of limb-shaking
in patients with TIAs or moderately disabling strokes associated with occlu-
sion of the ICA. They also sought to investigate whether the hemodynamic
state of the patients with limb-shaking is worse than in patients with
symptomatic ICA occlusion without limb-shaking.
The authors studied 34 patients (82% men; mean age, 62  7 years)
who had limb-shaking associated with ICA occlusion and 68 age-matched
and sex-matched controls who had hemispheric TIAs or minor disabling
strokes and ICA occlusion but who did not have limb-shaking. They
investigated collateral pathways using contrast angiograms and also studied
carbon dioxide reactivity measured by transcranial Doppler imaging.
Limb-shaking TIAs were found to last 5 minutes and were often
accompanied by paresis of the involved limb. Patients with limb-shaking
TIAs compared with controls more frequently had symptoms precipitated by
exercise or rising (odds ratio [OR], 14.2; 95% confidence interval [CI],
4.2-47.9). Patients with limb-shaking TIAs also more frequently had recur-
rent ischemic deficits after ICA occlusion before inclusion in this study (OR,
8.2; 95% CI, 2.3-29.3). Patients with limb-shaking TIA’s also tended to
have lower carbon dioxide reactivity (mean, 5%  16% vs 12%  17%; OR.
0.97 per 1% increase; 95% CI, 0.94-1.00). Patients with limb-shaking TIAs
had a greater dependence on leptomeningeal collaterals (OR, 6.8; 95% CI,
2.0-22.7).
Comment: Limb shaking as a manifestation of a TIA is a relatively
unknown to most vascular surgeons. Most of these patients have ICA
occlusion; 10% of patients with ICA occlusion will have limb-shaking TIAs.Some of these patients, however, have high-grade ICA stenosis rather than
occlusion and therefore are of interest to the peripheral vascular surgeon. It
is important to note that this particular form of TIA is likely hemodynamic
and not embolic. Patients with limb-shaking TIAs undergoing carotid
endarterectomy therefore, perhaps, should be strongly considered for shunt-
ing during the performance of the endarterectomy when technically feasible.
New Ischemic Brain Lesions onMRI after Stenting or Endarterectomy
for Symptomatic Carotid Stenosis: A Sub-Study of the International
Carotid Stenting Study (ICSS)
Bonati LH, Jongen LM, Haller S, et al and the ICSS-MRI study group.
Lancet Neurol 2010;9:353-62.
Conclusion: In a substudy of patients randomized in the International
Carotid Stenting Study (ICSS) comparing carotid artery stenting with
carotid endarterectomy for symptomatic carotid stenosis, patients random-
ized to the stenting group had three times more ischemic lesions found by
post-treatment magnetic resonance imaging (MRI) diffusion-weighted im-
aging (DWI) than patients randomized to the endarterectomy group. Ce-
rebral protection devices did not seem to be effective in preventing ischemic
DWI lesions after stenting.
Summary: The ICSS randomized patients with symptomatic carotid
artery stenosis to carotid stenting or carotid endarterectomy. Of the 50
centers that participated in the ICSS study, 7 took part in an MRI substudy,
the results of which were reported in this article. In the MRI substudy, MRI
was done 1 to 7 days before treatment (endarterectomy or stenting), at 1 to
3 days after treatment (post-treatment scan), and again at 27 to 33 days. The
primary end point of this substudy was the presence of at least one new
ischemic brain lesion on DWI on the post-treatment scan. Analysis was per
protocol, and investigators who read the scans were blinded to whether the
patient had received endarterectomy or carotid stenting.
The substudy comprised 231 patients (107 in the endarterectomy
group and 124 in the stenting group). The detection of one new DWI lesion
on post-treatment scans done a median of 1 day after treatment occurred
more frequently in the stenting group (50% of the 124 patients) than in the
endarterectomy group (17% of the 107 patients; odds ratio [OR], 5.21; 95%
confidence interval [CI], 2.78-9.79; P  .0001). There were changes at 1
month on fluid-attenuated inversion recovery sequences in 28 of 86 patients
(33%) in the stenting group and in 6 of 75 patients (8%) in the endarterec-
tomy group, (adjusted OR, 5.93; 95% CI, 2.25-15.62; P  .0003). In
centers with a policy of using cerebral protection devices, new DWI lesions
were present after treatment in 37 of 51 patients (73%) in the stenting group
and in 8 of 46 (17%) in the endarterectomy group (adjusted OR, 12.20; 95%
CI, 4.53-32.84). In centers with a policy of using unprotected carotid artery
stenting, new DWI lesions were present in 25 of 73 patients (34%) in the
stenting group and in 10 of 61 patients (16%) in the endarterectomy group
(adjusted OR, 2.70; 95% CI, 1.16-6.24; interaction P .019). Subanalyses
of age71 years, sex, whether the qualifying event was a TIA or stroke, and
whether there were DWI lesions present on the pretreatment scan all
indicated higher rates of new DWI lesions after stenting compared with
endarterectomy.
Comment: Previous nonrandomized studies have also suggested
higher rates of ischemic lesions detected on DWI imaging after stenting
compared with endarterectomy. A meta-analysis of these studies is presented
in Fig 4 of this article and indicated the OR of new ischemic lesion after
treatment was 6.71 (95% CI, 4.57-9.87) favoring endarterectomy. The
authors’ OR of 5.21 is very similar to that obtained from the meta-analysis.
The clinical significance of DWI lesions in the long run is unknown but is
postulated to eventually lead to cognitive decline and dementia (Pendlbury
ST et al [Lancet Neurol 2009;8:1006-18]). Of particular interest is the
apparent lack of protection against DWI lesions afforded by cerebral protec-
tion devices. One might postulate, given the relative ORs for DWI lesions
with and without protection devices, that protection devices actually in-
crease the risk of DWI lesions! There are a number of reasons why cerebral
protection devices may have been ineffective in this study. For instance, all
protection devices in this study were of the filter type, and conclusions about
other types of devices cannot be made. Another possible conclusion is that
cerebral protection during carotid artery stenting is another idea that seems
like a good idea but does not hold up to proper scrutiny when one actually
examines data collected by unbiased observers.
Patient Outcomes after Acute Pulmonary Embolism: A Pooled Survival
Analysis of Different Adverse Events
Klok FA, Zondag W, van Kralingen KW, et al. Am J Resp Critical Care Med
2010;181:501-6.
Conclusion: Within 4 years of acute pulmonary embolism (PE), half
the patients will have an additional serious adverse clinical event.
Summary: Most articles on acute PE focus on incidence and case
fatality rates. There are little data on the long-term fate of the patients. This
report, however, does provide a more long-term perspective of the fate of
patients with PE. We know that death related to PE occurs in approximately
